No Data
J.P. Morgan Maintains Twist Bioscience(TWST.US) With Sell Rating, Cuts Target Price to $33
Scotiabank Maintains Twist Bioscience(TWST.US) With Buy Rating, Maintains Target Price $62
Baird Maintains Twist Bioscience(TWST.US) With Buy Rating, Cuts Target Price to $44
Cathie Wood's ARK Investment Buys 283.2K Shares of Twist Bioscience Today
Twist Bioscience Is Maintained at Buy by Goldman Sachs
Guggenheim Reiterates Buy on Twist Bioscience, Maintains $50 Price Target